Indivior Pharmaceuticals, Inc. INDV Operating Income
Operating Income at other companies
Segments
By segment
See fullOther financials
Where this comes from
Reported directly by Indivior Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.
The official record: Indivior Pharmaceuticals, Inc. ’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Indivior Pharmaceuticals, Inc. 's operating income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Indivior Pharmaceuticals, Inc. 's operating income?
- Indivior Pharmaceuticals, Inc. (INDV) reported operating income of $137M in Q1 2026.
- How has Indivior Pharmaceuticals, Inc. 's operating income changed year-over-year?
- Indivior Pharmaceuticals, Inc. 's operating income increased by 107.6% year-over-year, from $66M to $137M.
- What is the long-term trend for Indivior Pharmaceuticals, Inc. 's operating income?
- Over 3 years (2022 to 2025), Indivior Pharmaceuticals, Inc. 's operating income has grown at a 50.4% compound annual growth rate (CAGR), from -$77M to $262M.
- What does operating income mean?
- Gross profit minus all operating expenses (SG&A, R&D, D&A). Measures the profit from core business operations before interest, taxes, and non-operating items.